US2016075993A1PendingUtilityA1
Medium for culturing stem cells
Est. expiryMay 30, 2033(~6.8 yrs left)· nominal 20-yr term from priority
Inventors:Yoko KuriyamaShou SendaYumi AndoTomomi YoshidaHaruna SatoDaisuke EjimaTakayoshi FujiiMasayo DateManabu Kitazawa
C12N 2501/998C12N 5/0602C12N 2500/36C12N 5/0696C12N 5/0018C12N 5/0606
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Culture media, which contain albumin carrying a reduced amount of fatty acid, are useful for culturing stem cells.
Claims
exact text as granted — not AI-modified1 . A medium for culturing stem cells, comprising an albumin which comprises a reduced amount of fatty acid.
2 . The medium according to claim 1 , wherein said albumin which comprises a reduced amount of fatty acid is obtained by subjecting albumin to a fatty acid removal treatment.
3 . The medium according to claim 2 , wherein said fatty acid removal treatment comprises treating albumin with activated carbon.
4 . The medium according to claim 1 , wherein said albumin comprises fatty acid in an amount of 0.1 mg/g to 0.65 mg/g, based on the total amount of said albumin.
5 . A medium for culturing stem cells, which comprises fatty acid in an amount of 0.1 mg to 0.65 mg per 1 g albumin in said medium.
6 . The medium according to claim 1 , wherein said fatty acid is a long chain fatty acid.
7 . The medium according to claim 1 , wherein said fatty acid is at least one member selected from the group consisting of oleic acid, palmitic acid, stearic acid, linoleic acid, linolenic acid, and arachidonic acid.
8 . The medium according to claim 1 , wherein said albumin is a human serum-derived albumin.
9 . A method of culturing stem cells, comprising cultivating stem cells in a medium according to claim 1 .
10 . The method according to claim 9 , wherein said stem cells are pluripotent stem cells.
11 . The method according to claim 10 , wherein said pluripotent stem cells are embryonic stem cells (ES cells) or induced pluripotent stem cells (iPS cells).
12 . A method of selecting an albumin suitable for addition to a medium, comprising:
measuring the amount of fatty acid comprised in an albumin; and selecting an albumin which comprises a reduced amount of fatty acid.
13 . A method of producing a medium for culturing stem cells, comprising:
preparing an albumin comprising a reduced amount of fatty acid by a fatty acid removal treatment; and adding said albumin comprising a reduced amount of fatty acid to a medium.
14 . The method according to claim 13 , wherein said fatty acid removal treatment comprises treating albumin with activated carbon.
15 . The method according to claim 14 , wherein said albumin is treated with 30 to 60 wt % of activated carbon, based on the weight of said albumin.
16 . The method according to claim 14 , wherein said treating albumin with activated carbon is conducted at a pH of 6.7 to 7.3.
17 . The method according to claim 14 , wherein said treating albumin with activated carbon is conducted at a pH of 3.7 to 4.3.
18 . The method according to claim 13 , wherein said albumin comprises fatty acid in an amount of 0.1 mg/g to 0.65 mg/g, based on the amount of albumin.
19 . The method according to claim 13 , wherein said fatty acid is a long chain fatty acid.
20 . The method according to claim 13 , wherein said fatty acid is at least one member selected from the group consisting of oleic acid, palmitic acid, stearic acid, linoleic acid, linolenic acid, and arachidonic acid.
21 . The method according to claim 13 , wherein said albumin is human serum-derived albumin.
22 . The medium according to claim 2 , wherein said albumin comprises fatty acid in an amount of 0.1 mg/g to 0.65 mg/g, based on the total amount of said albumin.
23 . The medium according to claim 3 , wherein said albumin comprises fatty acid in an amount of 0.1 mg/g to 0.65 mg/g, based on the total amount of said albumin.
24 . A cell culture, comprising stem cells in a culture medium according to claim 1 .
25 . The cell culture according to claim 24 , wherein said stem cells are pluripotent stem cells.
26 . The cell culture according to claim 25 , wherein said pluripotent stem cells are embryonic stem cells (ES cells) or induced pluripotent stem cells (iPS cells).Join the waitlist — get patent alerts
Track US2016075993A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.